Myeloproliferative Nephropathy Unmasks a Hematologic Diagnosis (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1250; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Hydroxyurea was initiated without response; he switched to ruxolitinib with improvement. With cytoreductive therapy and treatment of DN with empagliflozin, losartan, finerenone, and semaglutide, UACR fell to 189 mg/g with stable creatinine. Discussion In cases of renal biopsy findings suggestive of myeloproliferative nephropathy without definitively diagnosed myeloproliferative neoplasm, additional hematologic testing should be pursued."
Atypical Hemolytic Uremic Syndrome • Chronic Kidney Disease • Diabetes • Diabetic Nephropathy • Focal Segmental Glomerulosclerosis • Glomerulonephritis • Hematological Disorders • Metabolic Disorders • Myeloproliferative Neoplasm • Nephrology • Polycythemia Vera • Renal Disease • CFHR3 • JAK2 • LAMA5
|
|
Samira Mahesh Samant; Megan L. Troxell; Graham E. Abra
|